Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials

[1]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[2]  Philipp Dahm,et al.  Evidence‐based urology in practice: when to believe a subgroup analysis? , 2010, BJU international.

[3]  G. Guyatt,et al.  Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2) , 2009, Trials.

[4]  G. Guyatt,et al.  LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact , 2009, Trials.

[5]  Morten Wang Fagerland,et al.  Outcome based subgroup analysis: a neglected concern , 2009, Trials.

[6]  Douglas G Altman,et al.  Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols , 2008, BMJ : British Medical Journal.

[7]  G. Guyatt,et al.  Criteria for the Implementation of Research Evidence in Policy and Practice , 2008 .

[8]  Stephen W Lagakos,et al.  Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.

[9]  J. Fletcher,et al.  Subgroup analyses: how to avoid being misled , 2007, BMJ : British Medical Journal.

[10]  Holger J Schünemann,et al.  Misuse of Baseline Comparison Tests and Subgroup Analyses in Surgical Trials , 2006, Clinical orthopaedics and related research.

[11]  J. Habbema,et al.  Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? , 2006, American heart journal.

[12]  J. Habbema,et al.  Subgroup Analysis and Covariate Adjustment in Randomized Clinical Trials of Traumatic Brain Injury: A Systematic Review , 2005, Neurosurgery.

[13]  G. Guyatt,et al.  The sirens are singing: the perils of trusting trials stopped early and subgroup analyses. , 2005, Critical care medicine.

[14]  K. Schulz,et al.  Multiplicity in randomised trials II: subgroup and interim analyses , 2005, The Lancet.

[15]  Gordon Guyatt,et al.  Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results , 2005, Canadian Medical Association Journal.

[16]  P. Rothwell.  Subgroup analysis in randomised controlled trials: importance, indications, and interpretation , 2005, The Lancet.

[17]  Gordon H Guyatt,et al.  Users' guide to detecting misleading claims in clinical research reports , 2004, BMJ : British Medical Journal.

[18]  Carl van Walraven,et al.  Time-dependent bias was common in survival analyses published in leading clinical journals. , 2004, Journal of clinical epidemiology.

[19]  Sara T Brookes,et al.  Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. , 2004, Journal of clinical epidemiology.

[20]  Douglas G. Altman,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[21]  S. Pocock,et al.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems , 2002, Statistics in medicine.

[22]  Yi Tsong,et al.  ISSUES RELATED TO SUBGROUP ANALYSIS IN CLINICAL TRIALS , 2002, Journal of biopharmaceutical statistics.

[23]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice; Users' Guides to the Medical Literature: Essentials of Evidence-Based Clinical Practice , 2003, BMJ : British Medical Journal.

[24]  E. Susser,et al.  Reporting on methods of subgroup analysis in clinical trials: a survey of four scientific journals. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[25]  S. Assmann,et al.  Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.

[26]  D. Sackett,et al.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. , 1998, The New England journal of medicine.

[27]  Anna Donald,et al.  Getting Research Findings into Practice , 1998 .

[28]  J. Kirkpatrick,et al.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. , 1998, Journal of insurance medicine.

[29]  D. Sackett,et al.  Cochrane Collaboration , 1994, BMJ.

[30]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.

[31]  G H Guyatt,et al.  A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.

[32]  J. Wittes,et al.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.

[33]  S. Pocock,et al.  Statistical problems in the reporting of clinical trials. A survey of three medical journals. , 1987, The New England journal of medicine.

[34]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.